method of treating an autoimmune disorder, use of a tccr agonist, methods for increasing expression of il-10 and socs3 in lymphocytes, method for selection of tccr agonists, monoclonal antibody, hybridoma cell line, methods of treatment or suppression of an immune response and method of inhibiting the production of il-17, il-6 or gm-csf

摘要

TREATMENT METHOD OF AN AUTOIMMUNE DISTURBANCE, USE OF A TCCR AGONIST, METHODS FOR INCREASING IL-10 AND SOCS3 EXPRESSION IN LYMPHOCYTES, METHOD FOR SELECTING TCCR AGENTS, MONOCLONAL DENTAL HYDROLONOUS ANTIBODY, Suppression of an immune response and method of inhibiting IL-17, IL-6 or GM-CSF production. The present invention relates to methods of treating autoimmune disorders. In one embodiment, the present invention is directed to methods of treating autoimmune disorders comprising administering a TCCR agonist. In one embodiment, the autoimmune disorder is less partially mediated by a Th1 response. In one embodiment, the autoimmune disorder is at least partially mediated by CD8 + T cell proliferation.